Eyal Flom
Director/Miembro de la Junta en INNOCAN PHARMA CORPORATION .
Fortuna: 501 183 $ al 31/05/2024
Cargos activos de Eyal Flom
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INNOCAN PHARMA CORPORATION | Director/Miembro de la Junta | 25/09/2019 | - |
| Secretario Corporativo | 22/01/2020 | - | |
| REVIUM RECOVERY INC. | Director/Miembro de la Junta | - | - |
| Israeli Pharmaceutical Association | Consejero General | 01/04/1995 | - |
NurExone Biologic Ltd.
 NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Director/Miembro de la Junta | - | - |
Historial de carrera de Eyal Flom
Antiguos cargos conocidos de Eyal Flom.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NUREXONE BIOLOGIC INC. | Director/Miembro de la Junta | 15/06/2022 | 08/05/2023 |
Formación de Eyal Flom.
| University of Derby | Masters Business Admin |
| Tel-Aviv University | Graduate Degree |
Estadísticas
Internacional
| Israel | 6 |
| Canadá | 3 |
Operativa
| Director/Board Member | 4 |
| Corporate Secretary | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| INNOCAN PHARMA CORPORATION | Health Technology |
| NUREXONE BIOLOGIC INC. | Health Technology |
| REVIUM RECOVERY INC. | Distribution Services |
| Empresas privadas | 2 |
|---|---|
| Israeli Pharmaceutical Association | |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Health Technology |
- Bolsa de valores
- Insiders
- Eyal Flom
- Experiencia
